Abstract is: The North Central Cancer Treatment Group (NCCTG) is an international clinical research group sponsored by the National Cancer Institute. The NCCTG consists of a network of cancer specialists at community clinics, hospitals and medical centers in the United States, Canada and Mexico. The research base for NCCTG is located at Mayo Clinic in Rochester, Minnesota.
| (P625, lat/long) | 44.022548 / -92.46666 |
| organization | Q43229 |
| P646 | Freebase ID | /m/02rs9lc |
| P2427 | GRID ID | grid.477659.e |
| P6366 | Microsoft Academic ID | 2800547265 |
| P856 | official website | http://ncctg.mayo.edu/ |
| P6782 | ROR ID | 01a2yyy59 |
| P2002 | X username | alliance_org |
| P17 | country | United States of America | Q30 |
| P571 | inception | 1977-01-01 | |
| P131 | located in the administrative territorial entity | Rochester | Q486479 |
| P749 | parent organization | National Cancer Institute | Q664846 |
| P8687 | social media followers | 4785 |
| Q65381351 | AZD0530 in Treating Patients With Extensive Stage Small Cell Lung Cancer |
| Q65390106 | AZD2171 in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia |
| Q66037587 | Bortezomib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer |
| Q66036182 | CCI-779 in Treating Patients With Mantle Cell Non-Hodgkin's Lymphoma |
| Q66037096 | CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme |
| Q66034668 | CCI-779 in Treating Patients With Stage IIIB (With Pleural Effusion) or Stage IV Non-Small Cell Lung Cancer |
| Q65540672 | Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery |
| Q66037946 | Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer |
| Q65543282 | Cediranib Maleate in Treating Patients With Locally Advanced or Metastatic Liver Cancer |
| Q66035999 | Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
| Q66036585 | Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver |
| Q66037562 | Imatinib Mesylate in Treating Patients With Recurrent Small Cell Lung Cancer |
| Q66037742 | Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer |
| Q65384510 | Pazopanib in Treating Patients With Malignant Pleural Mesothelioma |
| Q66031472 | Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer |
| Q66036593 | Rituximab and Interleukin-12 in Treating Patients With B-Cell Non-Hodgkin's Lymphoma |
| Q66031394 | Sorafenib in Treating Patients With Metastatic Breast Cancer |
| Q66059210 | Sorafenib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer |
| Q65385994 | Sunitinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma |
| Q66034892 | Thalidomide in Treating Patients With Myelodysplastic Syndrome |
| Q66036246 | Thalidomide in Treating Patients With Myelofibrosis |
| Q66037450 | Thalidomide in Treating Patients With Relapsed Chronic Lymphocytic Leukemia |
| Q61933494 | VEGF Trap in Treating Patients With Metastatic Breast Cancer |
| Q65543300 | Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme |
| Q66037430 | Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy |
| Q66032774 | Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions |
| Q65387325 | Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial CAN-NCIC-MA27 |
| Q65390889 | Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity Caused By Oxaliplatin in Patients Receiving Combination Chemotherapy for Stage II, Stage III, or Stage IV Colorectal Cancer That Has Been Completely Removed By Surgery |
| Q66036782 | Chemotherapy Plus Radiation Therapy With or Without Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer |
| Q66038062 | Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer |
| Q64171079 | Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery |
| Q66035025 | Cisplatin Plus Etoposide With or Without Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer |
| Q66037246 | Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer |
| Q66032848 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the Esophagus |
| Q66037171 | Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer |
| Q66033618 | Combination Chemotherapy in Treating Patients With Stage III Colon Cancer |
| Q66033016 | Combination Chemotherapy in Treating Women With Breast Cancer |
| Q66035079 | Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes |
| Q65383876 | Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer |
| Q66035246 | Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast Cancer |
| Q65471962 | High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery |
| Q65473657 | Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) |
| Q66032859 | Immediate Compared With Delayed Chemotherapy in Treating Patients With Advanced Colorectal Cancer Without Signs or Symptoms of Disease |
| Q65381186 | Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy |
| Q66038319 | Letrozole After Tamoxifen in Treating Women With Breast Cancer |
| Q64716050 | Letrozole in Treating Women With Primary Breast Cancer Who Have Received 5 Years of Aromatase Inhibitor Therapy |
| Q66033910 | Marimastat or No Further Therapy in Treating Women With Metastatic Breast Cancer That Is Responding or Stable Following Chemotherapy |
| Q66038263 | Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma |
| Q66036419 | Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer |
| Q66033608 | Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma |
| Q65386263 | Radiation Therapy After Prostatectomy in Treating Patients With Stage III Prostate Cancer |
| Q66037796 | Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas |
| Q66038562 | Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma |
| Q66036696 | Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer |
| Q66037574 | Radiation Therapy in Treating Women Who Have Undergone Surgery for Early-Stage Invasive Breast Cancer |
| Q66037898 | S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer |
| Q66036009 | S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors |
| Q66059083 | S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer. |
| Q66032857 | S9415 Chemotherapy in Patients With Stage II or III Colon Cancer That Has Been Surgically Removed |
| Q66037906 | S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer |
| Q66037912 | S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy |
| Q66037554 | S9927 Radiation Therapy After Surgery, Chemotherapy, and/or Hormone Therapy in Stage II Breast Cancer |
| Q64673814 | SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer |
| Q66037263 | Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer |
| Q66035229 | Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer |
| Q66032852 | Talc in Treating Patients With Malignant Pleural Effusion |
| Q664846 | National Cancer Institute | has subsidiary | P355 |
| Q65472156 | Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ | sponsor | P859 |
| North Central Cancer Treatment Group | wikipedia |
Search more.